Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

4.32
Delayed Data
As of Mar 27
 -0.13 / -2.92%
Today’s Change
1.46
Today|||52-Week Range
6.37
+173.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization80.0K331.0K353.0K--
 
 
 
 
 
Operating ExpensesGross Income-80.0K-331.0K-353.0K0.00
 
 
 
 
General Expenses93.1M55.6M27.9M28.5M
 
 
 
 
 
Research And Development85.3M49.2M21.7M21.8M
 
 
 
 
 
Total Operating Expenses93.1M55.9M28.2M28.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-93.1M-55.9M-28.2M-28.5M
 
 
 
 
 
Interest Expense On Debt2.8M3.4M2.6M1.0M
 
 
 
 
 
Other Expenses606.0K-111.0K-15.0K-96.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-95.3M-59.4M-30.9M-29.6M
 
 
 
 
 
Net Income-95.3M-59.4M-30.9M-29.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.7M7.2M18.3M21.8M
 
 
 
 
 
Shares To Calculate EPS Diluted4.7M7.2M18.3M21.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$20.40-$8.24-$1.69-$1.36
 
 
 
 
 
EPS Diluted-$20.40-$8.24-$1.69-$1.36
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account